We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
-5.06%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$48.4B
AUM Growth
-$3.14B
Cap. Flow
-$231M
Cap. Flow %
-0.48%
Top 10 Hldgs %
30.2%
Holding
4,340
New
176
Increased
1,269
Reduced
1,824
Closed
174

Sector Composition

Rank Sector Weight
1 Technology 11.43%
2 Healthcare 8.99%
3 Financials 7.75%
4 Industrials 6.06%
5 Consumer Staples 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTOO
3826
DELISTED
T2 Biosystems, Inc
TTOO
$2K ﹤0.01%
4
NGM
3827
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$2K ﹤0.01%
138
+73
+112% +$1.11K
CPE
3828
DELISTED
Callon Petroleum Company
CPE
$2K ﹤0.01%
56
-779
-93% -$31.1K
WTER
3829
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$2K ﹤0.01%
333
-67
-17% -$475
IBHC
3830
DELISTED
iShares iBonds 2023 Term High Yield and Income ETF
IBHC
$2K ﹤0.01%
+80
New +$1.88K
ITCL
3831
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
$2K ﹤0.01%
669
CELL
3832
DELISTED
PhenomeX Inc. Common Stock
CELL
$2K ﹤0.01%
850
-793
-48% -$3.37K
RTL
3833
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$2K ﹤0.01%
323
-238
-42% -$1.76K
KDNY
3834
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$2K ﹤0.01%
84
VRAY
3835
DELISTED
ViewRay, Inc.
VRAY
$2K ﹤0.01%
448
+214
+91% +$718
VLTA
3836
DELISTED
Volta Inc.
VLTA
$2K ﹤0.01%
1,875
ATCO
3837
DELISTED
Atlas Corp.
ATCO
$2K ﹤0.01%
184
-236
-56% -$3.07K
POTX
3838
DELISTED
Global X Cannabis ETF
POTX
$2K ﹤0.01%
135
DZSI
3839
DELISTED
DZS Inc. Common Stock
DZSI
$2K ﹤0.01%
200
+53
+36% +$751
CTIC
3840
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$2K ﹤0.01%
329
+164
+99% +$1.02K
INBX
3841
DELISTED
Inhibrx, Inc. Common Stock
INBX
$2K ﹤0.01%
123
-19
-13% -$343
ABCL icon
3842
AbCellera Biologics
ABCL
$1.66B
$1K ﹤0.01%
+70
New +$768
ACEL icon
3843
Accel Entertainment
ACEL
$1.01B
$1K ﹤0.01%
+136
New +$1.38K
ACRS icon
3844
Aclaris Therapeutics
ACRS
$729M
$1K ﹤0.01%
+67
New +$1.06K
ADCT icon
3845
ADC Therapeutics
ADCT
$140M
$1K ﹤0.01%
300
ALXO icon
3846
ALX Oncology
ALXO
$268M
$1K ﹤0.01%
+65
New +$758
AMRC icon
3847
Ameresco
AMRC
$1.03B
$1K ﹤0.01%
12
-103
-90% -$6.33K
AMSC icon
3848
American Superconductor
AMSC
$1.36B
$1K ﹤0.01%
128
ANDE icon
3849
Andersons Inc
ANDE
$2.47B
$1K ﹤0.01%
22
-72
-77% -$2.5K
AORT icon
3850
Artivion
AORT
$1.33B
$1K ﹤0.01%
+70
New +$1.41K

Similar funds

US Bancorp's Q3 2022 Portfolio in Review

As of Q3 2022, US Bancorp held 4,340 positions worth $48.4B, down 6.1% from $51.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

US Bancorp's Q3 2022 filing shows 176 new, 1,269 increased, 1,824 reduced and 174 closed positions. Its largest new stake was Goldman Sachs Access Treasury 0-1 Year ETF: 30,834 shares worth $3.08M. The largest sale was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF, an estimated $271M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Healthcare and Financials.

  • US Bancorp's largest Q3 2022 buy was Goldman Sachs Access Treasury 0-1 Year ETF: 30,834 shares worth $3.08M.
  • US Bancorp added most to Vanguard FTSE Developed Markets ETF in Q3 2022, an estimated $241M increase.
  • US Bancorp's biggest Q3 2022 reduction was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF, cutting an estimated $271M.
  • US Bancorp fully exited PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES) in Q3 2022, selling an estimated $9.57M.
  • US Bancorp's ten largest holdings make up 30% of its $48.4B portfolio in Q3 2022.
  • US Bancorp opened 176 new positions and closed 174 in Q3 2022.
  • US Bancorp's portfolio value fell 6.1% quarter-over-quarter to $48.4B.

Based on US Bancorp's 13F filing for Q3 2022, filed 27 Oct 2022.